Clinical Trial

Long-term Safety Trial with NVDX3

Study acronym: X3LTFU
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
An study evaluating the long-term safety of all patients previously treated with NVDX3.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-29.
Status change: Not Yet Recruiting → Recruiting 2024-09-01
Trial Details
NCT Number NCT06532253
Lead Sponsor Novadip Biosciences
Collaborators: PrimeVigilance, Data Investigation Company Europe (DICE)
Conditions Distal Radius Fractures, Degenerative Lumbar Spondylolisthesis
Enrollment 15 participants
Start Date 2024-08-22
Primary Completion 2036-03 (estimated)
Study Completion 2036-03 (estimated)
Updated on ClinicalTrials.gov 2024-09-05